ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
NICE endorses Keytruda for bladder cancer
pharmatimes
March 19, 2018MSD’s Keytruda is the first and only immunotherapy to be recommended for NHS use to treat urothelial carcinoma patients, when prior platinum-containing chemotherapy fails. -
Lilly's Cyramza combo boasts strong results in bladder cancer
pharmafile
September 12, 2017Eli Lilly has announced new Phase 3 data at the European Society for Medical Oncology 2017 Congress which further add to the efficacy profile of Cyramza in treating platinum-refractory advanced urothelial carcinoma when used in combination with docetaxel. -
Roche’s Tecentriq hits trouble with NICE in bladder cancer
pharmaphorum
August 04, 2017NICE has said Roche’s cancer immunotherapy Tecentriq (atezolizumab) should not receive regular NHS funding as a treatment for bladder cancer in first draft guidance...
Pharma Sources Insight January 2025
